BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
Overview
patients om metformin from diabetic clinic were checked for bladder cancer
Full Title of Study: “BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Primary Purpose: Screening
- Masking: Single (Participant)
- Study Primary Completion Date: January 2014
Interventions
- Other: metformin
Arms, Groups and Cohorts
- Placebo Comparator: metformin
- metformin 500mg
- No Intervention: not on metformin
Clinical Trial Outcome Measures
Primary Measures
- Number of diabetic patients on metformin therapy
- Time Frame: 6 months
Participating in This Clinical Trial
Inclusion Criteria
- 150 people attending diabetic clinic Exclusion Criteria:
Gender Eligibility: All
Minimum Age: 25 Years
Maximum Age: 86 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- UFUOMA MILLER FAKPOR
- Provider of Information About this Clinical Study
- Sponsor-Investigator: UFUOMA MILLER FAKPOR, miss – University of Cape Coast
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.